BioSpace News Archive

AVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of its common stock.

RapidRona, a technology-enabled medical device company, announced today it has received Emergency Use Authorization (EUA) from the FDA for its SARS-CoV-2 sample self-collection kit.

Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Richard Peters, Chief Executive Officer, will present at the Piper Sandler 32nd Annual Virtual Healthcare Conference.

vTv Therapeutics Inc. announced it has entered into a common stock purchase agreement for up to $47 million with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.

China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, announced its unaudited financial results for the third quarter of 2020.

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced updated timing for its Fireside Chat presentation at an upcoming investor conference hosted by Evercore.

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and full year Fiscal 2020 ended August 31, 2020 on Monday November 30th, 2020 before market open.

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a Phase Ib/II clinical study of the company’s novel Bcl-2 inhibitor APG-2575,

The Hanukkah Special Gift Pack is Strictly Limited to 613 Units and is Priced at $106.13 per Unit

DEKA M.E.L.A. Srl, a laser and opto-electronics company engaged in the development of gynecological energy based devices and therapies for the treatment of women health diseases, announced the establishment of its Medical Advisory Board for Female Intimate Health.